1. Let us return to a more natural lifestyle

   • Kikuo Arakawa

   Invited Commentary Pages: 363 - 364

2. Web alert

   News Pages: 365 - 366

3. Literature alert

   • Robert A. Phillips

   Abstract Pages: 367 - 373

4. Three recently published trials in hypertension

   • Norman M. Kaplan

   Clinical Trials Review Pages: 377 - 378

5. Good news for the older patient with diabetes: added cardiovascular risk reduction

   • Donald G. Vidt

   Clinical Trials Review Pages: 379 - 380

6. Optimal blood pressure on antihypertensive medication

   • John M. Flack

   OriginalPaper Pages: 381 - 386

7. Clinical trials in isolated systolic hypertension

   • Jerzy Gasowski
   • Ji G. Wang
   • Jan A. Staessen

   OriginalPaper Pages: 387 - 393

8. Spectrum of use for the angiotensin-receptor blocking drugs

   • Maurice E. Fabiani
   • Colin I. Johnston

   OriginalPaper Pages: 394 - 401

9. Contemporary management of refractory hypertension

   • Arnold B. Alper Jr.
   • David A. Calhoun

   OriginalPaper Pages: 402 - 407

10. Hypertension: Goal systolic and diastolic blood pressure

    • Matthew R. Weir

    Clinical Trials Review Pages: 411 - 413

11. Is normotension good enough for the patient with type 2 diabetes?

    • Eberhard Ritz
    • Michael Schömig

    Clinical Trials Review Pages: 414 - 416

12. Antihypertensive therapy and progression of chronic renal disease

    • Lance D. Dworkin
    • Douglas G. Shemin

    OriginalPaper Pages: 417 - 422

13. Importance of blood pressure reduction for prevention of progression of renal disease

    • Stephen C. Textor
    • Vincent J. Canzanello

    OriginalPaper Pages: 423 - 430

14. Role of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in the prevention of progression of renal disease

    • C. Venkata S. Ram
    • Pedro Vergne-Marini

    OriginalPaper Pages: 431 - 435

15. Calcium-channel blockers and the progression of renal disease

    • Karen A. Griffin
    • Anil K. Bidani

    OriginalPaper Pages: 436 - 445

16. The case for combining angiotensinconverting enzyme inhibitors and calcium-channel blockers

    • Addison A. Taylor
    • Sarat Sunthornyothin

    OriginalPaper Pages: 446 - 453

17. Target blood pressure for antihypertensive therapy in patients with proteinuric renal disease

    • Lee A. Hebert

    OriginalPaper Pages: 454 - 460